Colorectal Cancer Clinical Trials in Baltimore

Showing 201-220 of 373 trials

COMPLETEDNA< 1 mile

Behavioral Weight Loss Program for Cancer Survivors in Maryland

NCT04534309

Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project

Breast CancerProstate CancerMelanoma (Skin)+5 more

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins340 participantsStarted Sep 2020

Baltimore, Maryland, United States

TERMINATEDPhase 3< 1 mile

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

NCT01011478

RATIONALE: Rosuvastatin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving rosuvastatin after surgery may kill any tumor cells that remain after surgery. It may also keep polyps from forming or colon cancer from coming back. It is not yet known whether rosuvastatin is more effective than a placebo in treating colon cancer that was removed by surgery. PURPOSE: This randomized phase III trial is studying rosuvastatin to see how well it works compared with placebo in treating patients with stage I or stage II colon cancer that was removed by surgery.

Colorectal CancerPrecancerous Condition

NSABP Foundation Inc406 participantsStarted Mar 2010

Anniston, Alabama, United States • Mobile, Alabama, United States • Fort Smith, Arkansas, United States +584 more locations

Behavioral Weight Loss Program for Cancer Survivors in Maryland

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Colorectal Cancer Trials in Other Cities

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"

Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

RObotic Versus LAparoscopic Resection for Rectal Cancer

Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

A Study of ADXS-NEO Expressing Personalized Tumor Antigens

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

Other Conditions in Baltimore